Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: November 3, 1999
Last updated: March 3, 2008
Last verified: June 2002
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2002
  Estimated Primary Completion Date: No date given